WOOJUNG BIO Inc (215380) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.033x

Based on the latest financial reports, WOOJUNG BIO Inc (215380) has a cash flow conversion efficiency ratio of -0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-809.75 Million ≈ $-548.76K USD) by net assets (₩24.58 Billion ≈ $16.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

WOOJUNG BIO Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how WOOJUNG BIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 215380 total debt and obligations for a breakdown of total debt and financial obligations.

WOOJUNG BIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of WOOJUNG BIO Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Gabriel Resources Ltd
V:GBU
0.080x
Molecure S.A.
WAR:MOC
0.266x
Alticast Corporation
KQ:085810
0.104x
Labiana Health S.A.
MC:LAB
0.604x
EasyJet PLC
LSE:EZJ
0.265x
Far East Gold Ltd
AU:FEG
-0.093x
RenovoRx Inc
NASDAQ:RNXT
-0.281x
TRF Limited
NSE:TRF
0.128x

Annual Cash Flow Conversion Efficiency for WOOJUNG BIO Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see WOOJUNG BIO Inc market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩29.37 Billion
≈ $19.91 Million
₩-1.13 Billion
≈ $-763.37K
-0.038x +73.85%
2023-12-31 ₩21.97 Billion
≈ $14.89 Million
₩-3.22 Billion
≈ $-2.18 Million
-0.147x -274.16%
2022-12-31 ₩29.72 Billion
≈ $20.14 Million
₩2.50 Billion
≈ $1.70 Million
0.084x +53.31%
2021-12-31 ₩31.46 Billion
≈ $21.32 Million
₩1.73 Billion
≈ $1.17 Million
0.055x +117.95%
2020-12-31 ₩28.03 Billion
≈ $19.00 Million
₩-8.57 Billion
≈ $-5.81 Million
-0.306x -4007.26%
2019-12-31 ₩26.66 Billion
≈ $18.07 Million
₩208.72 Million
≈ $141.45K
0.008x +134.30%
2018-12-31 ₩21.20 Billion
≈ $14.37 Million
₩-483.80 Million
≈ $-327.87K
-0.023x +82.39%
2017-12-31 ₩18.32 Billion
≈ $12.42 Million
₩-2.38 Billion
≈ $-1.61 Million
-0.130x +5.85%
2016-12-31 ₩10.57 Billion
≈ $7.16 Million
₩-1.46 Billion
≈ $-986.04K
-0.138x --

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology
Market Cap
$32.48 Million
₩47.93 Billion KRW
Market Cap Rank
#23456 Global
#1671 in Korea
Share Price
₩2875.00
Change (1 day)
-0.52%
52-Week Range
₩1427.00 - ₩3605.00
All Time High
₩13450.00
About

WOOJUNG BIO, Inc. provides non-clinical research agency services. The company was founded in 1989 and is based in Hwaseong-si, South Korea.